Latest in Ingredients

Rousselot and IamFluidics launch dissolvable microcarrier for cell culturing

The alginate and denatured collagen based product allows researchers to produce scalable cell cultures for biologic drugs and cell therapies

Find out more

How AI can optimise your pharmaceutical manufacturing processes and raise throughput

Artificial intelligence (AI) allows pharmaceutical manufacturers to perform predictive maintenance, which can reduce downtime and enhance process efficiency
See more

Logical Biological expands its raw pharma material development and supply capabilities with new lab

The raw material supplier can now better serve in vitro diagnostic (IVD) manufacturers, as it has a significantly larger operational capacity

Biosynth inaugurates its Biological Technology site in Suzhou, China

The new site will serve the Chinese domestic market, providing raw materials for vaccines and pharmaceuticals, while dealing regional distribution and handling

Seppic launches surfactant excipient for the optimisation of biological formulations

The ingredient is compatible with sensitive biologics, and aims to stabilise injectables for improved bioavailability, efficacy and shelf life

Beneo presents its taste-boosting excipient, galenIQ at CPHI 2024

galenIQ is designed to improve the flavour of oral solid dosage (OSD) forms for more patient-centric pharmaceuticals

Indena showcases its CDMO services and HPAPI capabilities at CPHI 2024

The company will display its range of high-potency APIs, as well as its ADC and linker payload development and manufacturing capabilities

Clariant introduces new high-performing excipients at the CPHI Milan 2024 trade show

Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI trade show in Milan

IFF Pharma Solutions brings new innovations and excipient excellence to CPHI 2024

IFF Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries

Novel innovation enhances productivity and output for Polish pharma company

A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up production and expand into new geographies

Latest posts in Ingredients

Agarose Bead Technologies expands its Spanish agarose resin manufacturing facility

The site is now capable of producing 100,000L of agarose resin per year, which pharma and bioprocessing professionals can use for CGT purification purposes

Bioiberica presents its potent API solutions at CPHI Milan

The company will be on hand to discuss its APIs and ingredients for pharmaceutical products, as well as its circular economy model

dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan

The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient

Sigrid Therapeutics' Glucose Stabiliser listed on US e-commerce site, GetHealthy.store

The non-pharmaceutical silica solution can assist patients in managing their blood sugar, while reducing bloating and increasing energy levels

CPHI Milan Annual Report 2024

Ahead of next month’s CPHI Milan — where the industry is expected to turnout in record numbers with a staggering 62,000 pharma executives expected from more than 100 countries — Manufacturing Chemist got a sneak preview of the CPHI Annual Reports Excipients Analysis featuring Ian Moore’s (former Chair of the IPEC Europe GMP Committee) personal predictions for the year ahead

The promising future of GLP-1s and oral peptides

Dr Andy Lewis, Chief Scientific Officer at Quotient Sciences, examines the trends driving the adoption of oral peptide products and discusses strategies to overcome the development challenges associated with effective delivery

The rise of nutraceuticals in the pharmaceutical industry

Driven by current market and consumer trends, pharmaceutical companies are increasingly embracing nutraceutical ingredients such as astaxanthin

Barentz acquires Anshul Life Sciences to bolster presence in the Indian market

The strategic acquisition will allow Barentz to distribute its pharmaceutical ingredients to India, a key location for market growth currently

Self-preservation: anti-crosslinking solutions secure the future of softgels

Fresh approaches to the issue of crosslinking in gelatin are paving the way for supplement and pharmaceutical manufacturers to exploit the growing demand for softgels, explains Dr Ulrich Mach, Head of Application Technology and Product Development, Performance Solutions, at GELITA

Aurorium launches Haelium Pharmaceutical Solutions

The creation will expand Aurorium's global capabilities in pharmaceutical ingredient production

ARTES and Basic Pharma near completion of their joint rHSA project

The collaborative project involved the production of recombinant human serum albumin (rHSA)

CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery

The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase

Sponsor content

Therapeutic: vimseltinib for tenosynovial giant cell tumour

Tenosynovial giant cell tumour (TGCT) is a rare, non-malignant tumour that results from a translocation in the colony stimulating factor 1 (CSF1) gene

Therapeutic: brensocatib for bronchiectasis

The chronic lung disease bronchiectasis is a serious condition in which the bronchi become permanently dilated because of a cycle of infection, inflammation and damage to...

New small-scale In-Line mixer range from Silverson Machines

Silverson launches versatile small-scale mixers for pharma and biotech applications

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Therapeutic: anticancer agent ivonescimab

The advent of PD-1 and PD-L1 targeting antibodies has transformed the outlook for many cancer patients by harnessing the body’s immune system to fight tumour cells

Therapeutic: seladelpar for primary biliary cholangitis

The chronic and progressive autoimmune liver disease, primary biliary cholangitis, affects the bile ducts running through the liver and slowly degrades them

C2 PHARMA marks 10 years at CPHI Milan with expanded ophthalmic APIs

The complany is ready to showcase its expanding ophthalmic API portfolio and global regulatory filings, featuring Naphazoline Hydrochloride and Tropicamide

C2 PHARMA expands ophthalmic API portfolio with Naphazoline Hydrochloride launch

C2 PHARMA, the global leader in ophthalmic and niche active pharmaceutical ingredients (APIs), proudly announces the launch of its latest API, Naphazoline Hydrochloride

Quotient Sciences and Vasa Therapeutics announce dosing of first subjects in VS-041 novel heart failure trial

The trial is designed to evaluate the safety, tolerability, and pharmacokinetics of VS-041 in healthy volunteers

ICROM has acquired HOLODIAG

ICROM srl, an italian API CDMO, has acquired the French-based Contract Research Organization HOLODIAG sas specialized in solid state studies and crystallization services...

Olon continues its growth with a new acquisition

The acquisition of Huvepharma Italia Srl increases production capacity and expands market presence

Familial chylomicronaemia syndrome: olezarsen

Familial chylomicronaemia syndrome (FCS) is a rare genetic disease that causes extremely high levels of triglycerides. It is the result of the enzyme lipoprotein lipase...

Featured companies

Olon Group is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical synthesis and... Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global... At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a... Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or...
See more